信隆健康
(002105)
| 流通市值：20.26亿 | | | 总市值：20.36亿 |
| 流通股本：3.64亿 | | | 总股本：3.66亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 1,073,497,217.55 | 717,097,027.34 | 359,564,905.91 | 1,187,687,703.11 |
| 营业总成本 | 1,090,917,168.89 | 725,270,304.61 | 360,133,901.34 | 1,218,348,833.32 |
| 其他经营收益 | | | | |
| 营业利润 | -22,710,895.07 | -12,755,413.63 | -1,124,039.21 | -73,108,451.72 |
| 利润总额 | -1,927,138.73 | 8,915,821.98 | -1,557,799.62 | -67,222,953.34 |
| 净利润 | -5,087,321.8 | 6,735,973.37 | -1,953,836.79 | -67,893,521.67 |
| 每股收益 | | | | |
| 其他综合收益 | -7,124,065.66 | -6,583,998.71 | -5,803,445.63 | -6,399,028.37 |
| 综合收益总额 | -12,211,387.46 | 151,974.66 | -7,757,282.42 | -74,292,550.04 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 926,023,123.52 | 959,667,135.01 | 950,376,757.28 | 965,656,909.32 |
| 非流动资产: | | | | |
| 非流动资产合计 | 674,067,869.25 | 673,873,359.01 | 686,729,389.66 | 698,207,345.15 |
| 资产总计 | 1,600,090,992.77 | 1,633,540,494.02 | 1,637,106,146.94 | 1,663,864,254.47 |
| 流动负债: | | | | |
| 流动负债合计 | 620,375,781.91 | 637,442,682.8 | 624,209,976.79 | 638,172,344.04 |
| 非流动负债: | | | | |
| 非流动负债合计 | 120,083,063.08 | 124,102,301.32 | 148,809,917.33 | 153,848,375.19 |
| 负债合计 | 740,458,844.99 | 761,544,984.12 | 773,019,894.12 | 792,020,719.23 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 797,366,976.99 | 808,151,485.88 | 798,668,083.25 | 804,528,708.81 |
| 股东权益合计 | 859,632,147.78 | 871,995,509.9 | 864,086,252.82 | 871,843,535.24 |
| 负债和股东权益合计 | 1,600,090,992.77 | 1,633,540,494.02 | 1,637,106,146.94 | 1,663,864,254.47 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,227,700,042.32 | 813,112,865.04 | 398,615,646.06 | 1,336,514,806.53 |
| 经营活动现金流出小计 | 1,149,557,171.47 | 753,682,423.52 | 384,286,947.32 | 1,279,119,936.71 |
| 经营活动产生的现金流量净额 | 78,142,870.85 | 59,430,441.52 | 14,328,698.74 | 57,394,869.82 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 6,433,152.55 | 4,746,821.52 | 333,983.93 | 18,138,192.01 |
| 投资活动现金流出小计 | 41,207,558.77 | 31,108,584.43 | 13,420,435.03 | 93,216,843.33 |
| 投资活动产生的现金流量净额 | -34,774,406.22 | -26,361,762.91 | -13,086,451.1 | -75,078,651.32 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 352,450,229.73 | 252,613,509.51 | 123,005,698.52 | 485,850,958.07 |
| 筹资活动现金流出小计 | 408,054,220.41 | 279,752,969.58 | 86,777,677.72 | 508,725,602.97 |
| 筹资活动产生的现金流量净额 | -55,603,990.68 | -27,139,460.07 | 36,228,020.8 | -22,874,644.9 |
| 汇率变动对现金及现金等价物的影响 | -17,219,528.69 | -13,167,467.38 | -2,839,976.96 | -3,630,428.58 |
| 现金及现金等价物净增加额 | -29,455,054.74 | -7,238,248.84 | 34,630,291.48 | -44,188,854.98 |
| 期末现金及现金等价物余额 | 309,809,224.35 | 332,026,030.25 | 373,894,570.57 | 339,264,279.09 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -7,238,248.84 | - | -44,188,854.98 |